- Report
- September 2022
- 256 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- July 2022
- 293 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP
- Report
- March 2022
- 270 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP
- Book
- June 2023
- 320 Pages
- Book
- February 2013
- 508 Pages
- Book
- August 2023
- 464 Pages
- Book
- March 2023
- 544 Pages
- Book
- September 2021
- 288 Pages
- Book
- January 2020
- 536 Pages
- Book
- August 2013
- 580 Pages
- Book
- June 2023
- 464 Pages
- Book
- June 2023
- 464 Pages

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more